It is widely recognized that depression may precipitate the incidence of dementia in the elderly individuals and individuals with amnestic mild cognitive impairment (aMCI) in particular. However, the association between subthreshold depression (SD) and cognitive deficits in patients with aMCI remains unclear. To address this, we collected demographic information and conducted a battery of neuropsychological cognitive assessments in 33 aMCI participants with SD (aMCI/SDþ), 33 nondepressed aMCI participants (aMCI/SDÀ), and 53 normal controls (NC). Both aMCI groups showed significantly poorer performance in most cognitive domains relative to the NC group (ie, memory, language, processing speed, and executive function). Notably, the aMCI/SDþ group showed significantly poorer attention/working memory compared with the aMCI/SDÀ group. Multiple linear regression analyses revealed a significant negative association between the severity of depressive symptoms and attention/working memory capacity (b ¼ À .024, P ¼ .024), accounting for 8.28% of the variations in this cognitive domain. All statistical analyses were adjusted by age, sex, and years of education. A logistic regression model had an accuracy of 72.4% in discriminating between the aMCI/SDþ and aMCI/ SDÀ groups based on individual cognitive profiles over 6 domains. Our findings indicate that patients with aMCI with and without SD have distinct patterns of cognitive impairment. This finding may facilitate the diagnosis and treatment of SD in patients with aMCI.
Introduction
Mild cognitive impairment (MCI) is defined as an intermediate stage in the cognitive continuum between healthy aging and dementia. 1 It is accompanied by an increased risk of developing dementia compared with elderly individuals without MCI, with an estimated annual conversion rate of 8% to 15%. 2 Amnestic mild cognitive impairment (aMCI) predominantly manifests as memory loss and is the most common MCI subtype. It is also the most likely to develop into Alzheimer disease (AD), with a conversion rate of approximately 10% to 15% per year. 3 Depressive symptoms in later life are strongly associated with cognitive decline and the occurrence of dementia and are regarded as early preclinical signs [4] [5] [6] [7] [8] or disease risk factors for dementia. [9] [10] [11] Furthermore, epidemiological studies have reported that comorbidity of aMCI and depressive symptoms is common in the elderly population, [12] [13] [14] [15] and individuals with both conditions exhibit more severe cognitive deficits and an increased risk of progression to dementia. [15] [16] [17] [18] Therefore, researchers have increasingly focused on the effect of depressive symptoms on cognitive decline in older adults with MCI.
Neuropsychological assessments are considered to be a convenient and powerful tool for evaluating cognitive impairment, mood, and behavioral symptoms. Cognitive profiles in patients with MCI with and without depression have been investigated using such instruments. However, the depression criteria used in previous studies to examine patients with MCI were heterogeneous. The core issue was whether meeting a clinical diagnosis of depression according to related diagnostic criteria. Some studies clearly defined major depressive disorder (MDD) in patients with MCI according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 19 Previous research found that patients with MCI with MDD exhibit poorer immediate visual recall and immediate logical memory compared with those without MDD. 17 Dong and colleagues (2016) also found that patients with MCI/MDDþ showed greater deficits in episodic memory (verbal and visual), executive function, and attention/processing speed compared with those without MDD. 20 These findings were consistent with work by Yoon and colleagues, who examined patients with MCI with both MDD and minor depression. 21 Other studies that measured depressive symptoms via questionnaires also reported that patients with MCI with depressive symptoms showed greater deficits in several cognitive domains, such as semantic memory, 22, 23 immediate memory, 21, 24 delayed memory, 21, 24 executive function, 21, 25 and attention. 21 All of these studies indicated that there exists a link between depression and MCI. However, whether the extent cognitive decline in depressed MCI participants is associated with depressive symptoms is not clear.
Previous studies on the relationship between MCI and depression have been limited in several ways. First, the criteria for depression are quite heterogeneous, and most epidemiological studies used insufficient techniques to confirm clinical diagnosis of depression or did not collect complete records regarding medical history of depressive symptoms. 7, 26, 27 This heterogeneity has reduced the comparability of study data regarding the impact of depression on cognition. Subclinical or subthreshold depression (SD), which is defined as the presence of relevant clinical symptoms of depression in individuals who do not meet the full criteria for a depression diagnosis, [26] [27] [28] is more common than MDD in elderly individuals 28 and patients with MCI. 29, 30 Compared with MDD, the mechanisms of SD may be more closely associated with the degenerative processes that underlie AD. 30 Second, MCI is a heterogeneous condition with different subtypes and levels of severity and is associated with various medical factors such as vascular burden. However, previous studies have nonetheless classified MCI into just 2 groups: aMCI and nonamnestic MCI. 1, 3 This could explain the discrepancies in the results of previous works on cognitive decline in patients with MCI with depression.
In the present study, we investigated the association between SD and cognitive deficits in patients with aMCI. We also examined the characteristics of specific cognitive domains and cognitive profiles in patients with aMCI with SD, as well as the association between cognitive deficits and the severity of depressive symptoms. Finally, we propose that patterns of cognitive deficit in patients with aMCI with SD may be distinct from those in nondepressed patients with aMCI.
Materials and Methods Participants
Sixty-six participants diagnosed with aMCI were recruited from the Dementia Care and Research Center (memory clinic) at Peking University Sixth Hospital (Institute of Mental Health), and 53 healthy participants were screened from local communities to form the normal control (NC) group. We collected demographic information from all participants through detailed clinical consultations, including age, sex, education level (years of education), history of depression, treatment information, and current medication use. All participants were drug-naive, right-handed, aged 55 to 85 years, and had an education level of no less than 5 years. This research was approved by the ethics committee of Peking University Sixth Hospital (Institute of Mental Health), and all participants provided written informed consent.
All participants received a neuropsychological and neuropsychiatric examination, and a geriatric psychiatrist provided a definitive diagnosis and Clinical Dementia Rating (CDR) 31 score after a clinical interview. The ability to carry out daily activities was assessed using the activities of daily living (ADL) scale, 32, 33 where a score of 26 or less was used to indicate the absence of significant detriments to essential daily living ability. We used the modified Hachinski Ischemic Scale (mHIS) 34 to exclude individuals with vascular cognitive impairment (indicated by a score 4).
Participants with aMCI were required to meet the established diagnostic and classification criteria proposed by Petersen in 2004, 35 which are as follows: (1) complaints of memory disorders that can be confirmed by informants, (2) confirmation of objective memory impairment that does not match age by neuropsychological assessment, (3) preserved general cognitive function, (4) intact or only mildly impaired daily living ability (an ADL score 26), and (5) the absence of dementia according to the dementia diagnostic criteria of the International Classification of Diseases and Related Health Problems 10th Revision. 36 Mini-Mental State Examination (MMSE) scores ! 24 were considered to indicate preserved general cognitive function in the aMCI group, and the cutoff score was ! 26 for the NC group. 37 The Global CDR requirement in the aMCI group was 0.5, and that in the NC group was 0.
The eligibility criteria for the NC group (n ¼ 53) were as follows: did not meet clinical criteria for cognitive impairment or depression, either historically or currently, and the absence of any subjective complaints of cognitive decline.
Exclusion criteria for all participants were as follows: (1) currently taking antidementia drugs or antidepressants; (2) history of stroke, subdural hematoma, tumor, other intracranial space-occupying diseases or cerebrovascular disorders, and presence of significant risk factors for cerebrovascular disorders (ie, a score higher than 4 on the mHIS 34 ); (3) a history of drug or substance abuse; (4) current or previous neuropsychiatric diseases such as Parkinson disease, epilepsy, schizophrenia, and other affective disorders; and (5) presence of a physical illness that could affect cognition or emotion, such as low folate levels or vitamin B 12 levels, hypothyroidism, and severe visual and auditory disorders.
Assessment of Depressive Symptoms
Depressive symptoms were evaluated using the Chinese version of 30-item Geriatric Depression Scale (GDS). 38, 39 The GDS is commonly used to assess depression in elderly individuals and scores equal to or higher than 10 indicate the presence of depression. 38, 40 We used this operational definition (GDS ! 10) to determine the presence of SD in participants who presented with a clinical impression of depression but did not exhibit sufficient symptoms to meet the full criteria for a diagnosis of major depression or bipolar disorder [26] [27] [28] according to the DSM-5. 41 We then generated 2 aMCI subgroups based on whether the participants had SD: those with aMCI without SD (aMCI/SDÀ, n ¼ 33) and those with aMCI with SD (aMCI/ SDþ, n ¼ 33). All subjects in the aMCI/SDÀ group showed no depressive symptoms as assessed by a senior psychiatrist during clinical visits.
Neuropsychological Assessment
The neurocognitive functions of all participants were assessed using a comprehensive neuropsychological battery that assessed numerous cognitive domains including memory, visuospatial ability, language, attention/working memory, processing speed, and executive function. General cognitive function was determined using the Chinese version of MMSE 42 and the Beijing version of the Montreal Cognitive Assessment (MoCA). 43 Memory was assessed using the Common Objects Memory Test (taken from the Chinese version of Cross-Cultural Neuropsychological Test Battery [CCNB] 44 ), logical memory subtests from the Wechsler Memory Scale-Revised for China (WMS-RC), 45 Hopkins Verbal Learning Test-Revised (HVLT-R), 46 and the Brief Visuospatial Memory TestRevised (BVMT-R). 47 Language was evaluated using the animal Verbal Fluency Test (aVFT) 48 and auditory comprehension (AC, which is from the CCNB) test. Visuospatial ability was examined using the constructional praxis (CP, which is also from the CCNB) test. Attention/working memory was assessed using the Digit Span (DS) subtest of the Wechsler Adult Intelligence Scale-Revised for China (WAIS-RC) 49 and the WMS-RC Spatial Span (SS) subtest. The DS and SS tests are commonly used to assess attention and verbal/spatial working memory, while the forward span tests are more closely related to attention and the backward span tests are more dependent on working memory. 50 Working memory capacity may reflect basic attentional control capability, and thus may be considered to be a more general control capability, 51 so we combined the 2 subtests. We examined processing speed using the Trail Making Test A (TMT-A) 52 and WAIS-RC Digital Symbol Test (DST) subtest. Executive function was assessed using the Stroop Color-Word Test (Stroop CW) 53 and the Wisconsin Card Sorting Test (WCST). 54 The specific content of the cognitive assessments is shown in Table 1 .
For all scales, we used Chinese versions that had been verified in terms of reliability and validity. More specifically, HVLT-R, BVMT-R, aVFT, TMT-A, Stroop CW, and WCST were from the Chinese version of the Measurement and Treatment Study for Improving Cognition of Schizophrenia Consensus Cognitive Battery, which has been well validated in China through previous studies. 55 
Statistical Analyses
Statistical analyses were conducted using SPSS (version 23.0, IBM) for MacOS. Between-group differences in the categorical variable (sex) were analyzed using the R Â C w 2 test. Continuous variables were compared between groups using analyses of covariance (ANCOVAs) and post hoc tests with the Bonferroni correction, controlling for the covariate effects of age, sex, and years of education. For the variables that showed a skewed distribution, we used a permutation-based nonparametric ANCOVA 56 for between-group comparisons with 5000 iterations. To examine the association between the severity of depression and that of cognitive impairment, we applied a multiple linear regression model to the data from all aMCI participants. The model was constructed with the GDS scores, age, sex, and years of education as the independent variables and with the tests scores in which we found significant differences between the aMCI/SDþ and aMCI/SDÀ subgroups as the dependent variables, using the "enter" method (2-sided tests). We controlled for the covariates of age, sex, and years of education and evaluated the degree to which the GDS scores could explain this model based on the determinate coefficient. The significance level was set at P < .05.
To assess patterns of cognitive impairment in participants with aMCI/SDþ, we standardized the raw scores of each assessment (ie, z scores) using the mean and standard deviation of the counterpart domain in the NC group as the reference for each participant. 57 Then, we further calculated the composite z scores for each cognitive domain for each participant by averaging the z scores over all the assessments in each cognitive domain. Finally, we averaged all adjusted composite z scores for each cognitive domain across the participants in each group, after controlling for age, sex, and education level, and generated a radar chart of cognitive profiles for the 3 groups. We performed ANCOVA and subsequent post hoc analyses for all z scores and explored the association between GDS scores and z scores using the same multiple linear regression model as that used for the raw scores. We constructed a multiple logistic regression model with individual 6-dimensional cognitive z scores as independent variables and with 0 and 1 as a dichotomous outcome (0: aMCI/ SDÀ; 1: aMCI/SDþ), using the "enter" method (2-sided tests) over all aMCI participants, and calculated the accuracy of discrimination between the aMCI/SDþ and aMCI/SDÀ groups.
Results

Demographic and Clinical Characteristics
The demographic and clinical data are shown in Table 1 . We found no significant between-group differences in age or sex (age: P ¼ .065; sex: P ¼ .205). The education level of the aMCI/SDÀ group was significantly higher than that of the aMCI/SDþ group (P ¼ .001). The GDS scores in the aMCI/ SDþ group were significantly higher than those in the NC and aMCI/SDÀ groups (Ps < .001), while the GDS scores in the aMCI/SDÀ group were not significantly different from those in the NC group (P ¼ .500). 
Neuropsychological Assessments
The ANCOVA, which was adjusted for age, sex, and education, revealed that almost all individual neuropsychological measures were significantly different between the 3 groups, except for the raw scores for AC (language), CP (visuospatial ability), the Spatial Span Backward (SSB) task (attention/ working memory), and the TMT-A (processing speed; Table  1 ). Concerning general cognitive function, there were no significant differences in total MMSE or MoCA scores between the aMCI/SDþ and aMCI/SDÀ groups (MMSE: P ¼ .069; MoCA: P ¼ .561), although scores in both of these groups were significantly lower than those in the NC group (Ps < .001; Table 1 ). Bonferroni post hoc comparisons revealed that compared with the aMCI/SDÀ group, the aMCI/SDþ group displayed poorer performance on the Digit Span Forward (DSF), Digit Span Backward (DSB), and Spatial Span Forward (SSF) tests of attention/working memory (DSF: P ¼ .011; DSB: P ¼ .014; SSF: P ¼ .014; Table 1 ). Digit Span Backward and SSF scores in the aMCI/SDþ group were significantly lower than those in the NC group (DSB: P ¼ .001; SSF: P ¼ .002), although there were no significant differences between the 2 groups in terms of DSF scores (P ¼ .020, uncorrected). There were no differences in DSF, DSB, or SSF scores between the aMCI/SDÀ and NC groups. Further, there were no significant between-group differences in SSB scores between the 3 groups (P ¼ .088).
Moreover, the aMCI/SDþ and aMCI/SDÀ groups exhibited significantly poorer performance compared with the NC group in terms of memory, language, processing speed, and executive function. Brief Visuospatial Memory Test-Revised total recall and delayed recall scores in the aMCI/SDÀ group were significantly lower than those in the NC group (Ps < .001), while there were no significant differences in these measures between the aMCI/SDþ and NC group. Digit Symbol Test scores and WCST perseverative errors (WCST_pe) revealed poorer performance in the aMCI/SDþ group compared with the NC group (DST: P ¼ .001; WCST_pe: P ¼ .001), while there were no significant differences in performance between the aMCI/ SDÀ and NC groups (Table 1) .
Cognitive Composite Scores and Profiles
The z scores data were consistent with the results of the raw scores. A cognitive radar map showing profiles over 6 domains for the 3 groups, adjusted for age, sex, and education level is shown in Figure 1A . As can be seen in the figure, the patterns of cognitive deficits were visually different between the 2 subgroups of patients with aMCI. The ANCOVA and post hoc analysis of the composite z scores for the cognitive domains showed that the aMCI/SDþ group had significantly weaker performance than the aMCI/SDÀ group in terms of attention/ working memory (P < .001; Table 2, Figure 1B) . No significant differences in other domains were found between the aMCI/ SDþ and aMCI/SDÀ groups ( Table 2) . A logistic regression model was constructed based on individual 6-dimensional cognitive patterns over 58 aMCI participants (4 aMCI/SDþ patients and 4 aMCI/SDÀ patients were excluded due to incomplete cognitive domains). This model had 72.4% accuracy in discriminating between the aMCI/SDþ and aMCI/SDÀ groups ( Figure 1C ).
Associations Between Depression Severity and Cognitive Decline
The multiple linear regression model revealed an association between GDS score and composite attention/working memory score (b ¼ À.024, P ¼ .024), adjusted for age, sex, and education level. It accounted for 8.28% of the decrease in performance in terms of attention/working memory capability (Table 3, Figure 2 ). However, no other variables were found to be significantly associated with GDS.
Discussion
We investigated the characteristics of cognitive deficits in participants with aMCI and concomitant SD (aMCI/SDþ), as well as the association between cognitive deficits and the severity of depressive symptoms. The aMCI/SDþ group exhibited significantly poorer performance on attention/working memory tasks compared with the other 2 groups (DSF, DSB, and SSF scores), although there were no significant differences in general cognition (MoCA and MMSE) between the aMCI/SDþ and aMCI/ SDÀ groups. Multiple linear regression analyses further revealed a significant negative association between the severity of depressive symptoms and attention/working memory capacity, after controlling for age, sex, and education level, and it partially accounted for the observed variation in this cognitive domain. We constructed a logistic regression model based on individual 6-dimensional cognitive patterns over 58 aMCI participants. The model had 72.4% accuracy in discriminating between the aMCI/SDþ and aMCI/SDÀ groups.
Overall, both aMCI subgroups showed significant disruption in most cognitive domains relative to the NC group (ie, memory, language, processing speed, and executive function). However, only the aMCI/SDþ group showed significantly poorer performance in attention/working memory, which was preserved in the aMCI/SDÀ groups. Post hoc analysis further revealed that the aMCI/SDþ group showed significantly greater deficits in attention/working memory than the aMCI/ SDÀ group (raw DSF, DSB, and SSF scores and the composite z score). This finding has been previously reported in patients with aMCI/MDDþ, although researchers also found poor performance in other domains such as episodic memory, executive function, and processing speed. 20, 21 While Hudon and colleagues (2008) did not assess attention/working memory, they found that patients with aMCI/SDþ showed significantly poorer executive function compared with nondepressed patients with aMCI. 25 In a longitudinal study that examined a community-dwelling cohort, participants with late-life depression exhibited a greater decline in attention/working memory and episodic memory than nondepressed individuals. 8 In the current study, we found that the aMCI/SDþ group tended to have lower executive function and processing speed than the aMCI/SDÀ group, although these differences were not significant. These domains are considered to be core cognitive impairments that are characteristic of MDD. 58 It is possible that we did not find significant differences in executive function and processing speed between the aMCI/SDþ and aMCI/ SDÀ groups because the existing depressive symptoms were relatively mild. Nonetheless, our research suggests that depression primarily impacted attention/working memory in patients with aMCI. The significant differences in cognitive deficits in the aMCI/ SDþ group may be due to the heterogeneity of aMCI rather than the effects of depressive symptoms. Cognitive impairment is considered to be a core symptom of depression, 8, 59 independent of whether the depression is episodic, 59 or if patients experience clinical remission. 5, 8 In the present study, our multiple regression analyses revealed a significant association between depression severity and attention/working memory capacity in aMCI participants, indicating that greater depression severity in patients with aMCI is associated with greater deficits in attention/working memory. The neural correlates of depression-induced deficits in attention/working memory have been explored in previous studies. Particularly, chronic depressive symptomatology has been associated with accelerated cortical atrophy in the frontal lobe and anterior cingulate in patients with MCI. 60, 61 This neural network is involved in attention/working memory processes. 62, 63 White matter microstructure abnormalities in this network have been found in Figure 1 . Differences in cognitive profiles between the aMCI/SDþ, aMCI/SDÀ, and NC groups. A, Cognitive profiles over 6 cognitive domains of the NC (black), aMCI/SDþ (red), and aMCI/SDÀ (blue) groups after adjusting for age, sex, and education. B, A violin plot showing the data distribution of z scores for attention/working memory. C, A logistic regression for discriminating between the aMCI/SDþ and aMCI/SDÀ groups. Significant differences between groups are indicated by *** (corrected P < .001). aMCI/SDþ indicates amnestic mild cognitive impairment with subthreshold depression; aMCI/SDÀ, amnestic mild cognitive impairment without subthreshold depression; NC, normal control; SD, subthreshold depression.
patients with late-life depression. 64, 65 Unfortunately, geriatric depression does not always manifest as depression-specific symptoms (such as feelings of sadness) and can instead be associated with physical discomfort, insomnia, suspiciousness, irritability, fatigue, and loss of appetite. 66 Therefore, it can be difficult to detect depressive symptoms based on typical clinical manifestations in the clinic. Thus, assessing whether patients with aMCI with attention/working memory defects have potential SD could significantly impact their prognosis.
Our data indicate that full assessments of cognitive impairment (ie, cognitive profiles that include all cognitive domains) may be important in distinguishing depressed from nondepressed patients with aMCI. Depressed patients with MCI have been found to be more likely to develop dementia and also more likely to experience cognitive decline. [4] [5] [6] [7] [8] 10 Thus, diagnosing and treating depression in people with MCI could improve the quality of life of both patients and caregivers and delay the progression to dementia. 67 Our results suggest that early identification of geriatric depression via patterns of Figure 2 . Correlation between GDS and cognitive impairment. Negative correlation between the severity of depression (GDS score) and attention/working memory performance are shown. Shaded areas indicate 95% confidence intervals. GDS indicates Geriatric Depression Scale. cognitive impairment is possible in patients with aMCI. We identified 2 distinct profiles of cognitive deficit in participants with aMCI/SDþ and aMCI/SDÀ. Thus, participants with aMCI and concomitant subthreshold or subclinical depression may exhibit specific patterns of cognitive impairment even though they have the same levels of general cognition as nondepressed patients with aMCI. Such insights could facilitate the early diagnosis of depressive symptoms in individuals with aMCI from the perspective of cognitive profiles.
The present study has several limitations. First, because of the limited sample size, conclusions drawn from our subgroup analyses be interpreted with caution, and future work should employ larger sample sizes. Besides, the group of aMCI participants in this study may include both single-domain aMCI and multi-domain aMCI, which could have obscured some potential differences between the subgroups of the aMCI. Second, in the current data set, the aMCI/SDÀ group showed significantly more years of education than the aMCI/SDþ group, although education level did not appear to have a strong influence on the results. Indeed, many studies have reported that education did not moderate the rate of cognitive decline in older people 68, 69 but only affected the incidence of dementia via increasing cognitive reserves. 70 Additionally, we adjusted for the years of education as a covariate in the statistical analyses, such that education level was an independent variable. Further, although any participant with MDD was excluded from our sample population in this study according to the clinical diagnosis of the DSM-5 guideline, several patients with aMCI/SDþ showed high GDS scores, and they may have severe depressive symptoms. Controlling for the upper limit of GDS should be considered in future work. Finally, this was a cross-sectional study, therefore the causality between variables and the long-term effects of depression and treatment on cognitive impairment (especially attention/working memory) could not be examined. However, our data may provide insights regarding the divisions between different MCI subtypes. Longitudinal studies including those with multiple biomarkers are required to examine potential common neuropathophysiological features and new possibilities for clinical assessment.
In conclusion, this study found a negative association between SD and neurocognitive functioning in aMCI patients, particularly attention/working memory. We found that participants with aMCI and concomitant SD could be characterized by a specific pattern of cognitive impairment and distinguished from nondepressed patients with aMCI. This study may provide insights regarding the early diagnosis and treatment of SD in patients with aMCI. Further neurobiological studies should aim to clarify the mechanisms of depression-related changes in cognition in patients with MCI.
